Pfizer

EU commissioner widens pharma probe

admin — Thu, 15 May 2008 06:59:55 -0400

Europe's competition commissioner is casting a wide net in her pharma-market antitrust probe. After questioning some 100 companies--including Pfizer, GlaxoSmithKline, and Read more...

SPOTLIGHT: Pfizer to disclose grants, donations

admin — Thu, 15 May 2008 06:59:52 -0400

Pfizer is pledging "greater transparency" in its dealings with medical, scientific, and patient organizations; its first step is disclosing all grants and charitable contributions for the first Read more...

Rumor Mill: Pfizer eyeing MediGene

admin — Wed, 14 May 2008 06:59:54 -0400

Rumors are swirling that Pfizer is looking to take over the German biotech Read more...

Painkillers little help against dementia

admin — Tue, 13 May 2008 06:59:54 -0400

Hopes that painkillers might help stave off Alzheimer's disease were dampened by a large new study. Pfizer's Celebrex and the over-the-counter Aleve didn't benefit thinking skills as researchers had Read more...

SPOTLIGHT: Ex-Exubera plant to shut down

admin — Tue, 13 May 2008 06:59:52 -0400

Pfizer will shutter its sterile manufacturing plant in Terre Haute--where the now-defunct inhaled insulin product Exubera was made--by mid-2009, eliminating the facility's remaining 140 jobs. More Read more...

Silver lining to Big Pharma's cloud?

admin — Fri, 09 May 2008 06:59:56 -0400

Some people see the Big Pharma glass as half-full instead of the alternative. In an investor's-eye look at the industry, Kiplinger ticks off the usual criticisms: patent expirations, tough generics Read more...

SPOTLIGHT: Feds tout Chantix in stop-smoking guidelines

admin — Thu, 08 May 2008 06:59:52 -0400

The federal government's new stop-smoking guidelines recommend Chantix, the Pfizer drug that has been linked to depression and suicidal behavior, saying that the drug's effectiveness outweighs those Read more...

BMS: Buyer or buyout target?

admin — Wed, 07 May 2008 06:59:58 -0400

Market-watchers love to speculate. Their latest topic? Bristol-Myers Squibb, which has been paring away its "non-core" businesses over the last few months. Most recently, Bristol agreed to Read more...

New Canadian rules to delay big generics

admin — Tue, 06 May 2008 06:59:56 -0400

Generics makers are up in arms over proposed patent rules in Canada. The drug copycats say the rules will delay generic Lipitor and several other blockbusters by as much as two years. (Can you hear Read more...

Pfizer starts settling Celebrex claims

admin — Mon, 05 May 2008 06:59:58 -0400

Pfizer is starting to settle the thousands of lawsuits over painkillers Celebrex and Bextra, the Wall Street Journal reports. Three groups of plaintiffs who allege that the meds caused heart attacks Read more...